Adavivint, also known as SM04690, is a small-molecule inhibitor of the Wnt pathway which is being investigated as a potential disease modifying agent for the treatment of osteoarthritis of the knee

T26563

C29H25ClFN7O

542.02

SM04690;SM 04690;SM-04690;Adavivint HCl;Adavivint;Adavivint HCl (1467093-03-3 free base)

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years